Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool

• Κύριοι συγγραφείς: Xiao-yi Bao (Συγγραφέας), Qun Zheng (Συγγραφέας), Qiang Tong (Συγγραφέας), Peng-chong Zhu (Συγγραφέας), Zhuang Zhuang (Συγγραφέας), Guo-qing Zheng (Συγγραφέας), Yan Wang (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2018-12-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Background: Danshensu (DSS) possesses unique bioactivity on the cardiovascular system. However, there is a lack of systematical summary of DSS for acute myocardial ischemia injury and no quality assessment tool for the systematical review of cell experiments. Here, we aimed to assess the preclinical...